DENISE MARTINEAU: Open Payments
NPI 1205920501 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$371 in 19 payments from 13 companies in 2025. Trend: 2023 $579 · 2024 $723 · 2025 $371
Food & beverage: $371
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $78 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| Exact Sciences Corporation | 2 | $35 |
| Seqirus USA Inc | 1 | $25 |
| PFIZER INC. | 1 | $25 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $23 |
| Novo Nordisk Inc | 1 | $22 |
| Astellas Pharma US Inc | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
Products named: QULIPTA, Cologuard Collection Kit, Flucelvax, PREVNAR 20, Quviviq, VIBERZI, Veozah, LINZESS.
Industry payments across OK — which companies pay providers there.
